Drug delivery applications and future prospects of microbial exopolysaccharides.

Q3 Medicine Polimery w medycynie Pub Date : 2023-07-01 DOI:10.17219/pim/176590
Tioluwani Ibukun Adegbolagun, Olubusola Ayoola Odeniyi, Michael Ayodele Odeniyi
{"title":"Drug delivery applications and future prospects of microbial exopolysaccharides.","authors":"Tioluwani Ibukun Adegbolagun, Olubusola Ayoola Odeniyi, Michael Ayodele Odeniyi","doi":"10.17219/pim/176590","DOIUrl":null,"url":null,"abstract":"<p><p>Over the years, exopolysaccharides (EPSs) have been utilized in various areas of research, including health, industry, environment, and agriculture, due to their flexible physical, chemical and structural properties that can be readily modified to suit desired purposes. Current research trends have shown that EPS production is dependent on numerous factors which can be combined to varying extent to optimize production yields. Although the majority of research is directed towards their industrial and medicinal uses, these chemical substances possess peculiar characteristics which are also exploited for biomedical research, where they are being used as drug delivery systems, some of which include their abundance in nature, biocompatibility, biodegradability, non-toxicity, and ability to efficiently encapsulate sensitive bioactive agents. However, despite the numerous beneficial prospects of microbial EPSs in drug delivery, there are limitations to the commercial production and industrial applications of these biopolymers. These limitations have inspired revolutionary research into the cost-effective production of safe EPSs polymers. In this review, we classify EPSs and discuss their methods of extraction and characterization. We also summarized current drug delivery applications and discussed limitations to extensive industrial commercialization of EPSs, while highlighting prospects for the utilization of microbial EPSs and implications for research.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":" ","pages":"117-127"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polimery w medycynie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17219/pim/176590","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Over the years, exopolysaccharides (EPSs) have been utilized in various areas of research, including health, industry, environment, and agriculture, due to their flexible physical, chemical and structural properties that can be readily modified to suit desired purposes. Current research trends have shown that EPS production is dependent on numerous factors which can be combined to varying extent to optimize production yields. Although the majority of research is directed towards their industrial and medicinal uses, these chemical substances possess peculiar characteristics which are also exploited for biomedical research, where they are being used as drug delivery systems, some of which include their abundance in nature, biocompatibility, biodegradability, non-toxicity, and ability to efficiently encapsulate sensitive bioactive agents. However, despite the numerous beneficial prospects of microbial EPSs in drug delivery, there are limitations to the commercial production and industrial applications of these biopolymers. These limitations have inspired revolutionary research into the cost-effective production of safe EPSs polymers. In this review, we classify EPSs and discuss their methods of extraction and characterization. We also summarized current drug delivery applications and discussed limitations to extensive industrial commercialization of EPSs, while highlighting prospects for the utilization of microbial EPSs and implications for research.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
微生物外多糖的药物输送应用和未来前景。
多年来,外多糖(EPS)因其灵活的物理、化学和结构特性而被广泛应用于健康、工业、环境和农业等多个研究领域,并可根据需要随时进行改良。目前的研究趋势表明,发泡聚苯乙烯的生产取决于许多因素,这些因素可在不同程度上相互结合,以优化产量。虽然大多数研究都是针对其工业和医药用途,但这些化学物质所具有的特殊性质也被用于生物医学研究,在生物医学研究中,它们被用作药物输送系统,其中包括其在自然界中的丰富性、生物相容性、生物降解性、无毒性以及有效封装敏感生物活性剂的能力。然而,尽管微生物发泡聚苯乙烯在给药方面有许多有益的前景,但这些生物聚合物的商业生产和工业应用却受到限制。这些限制激发了人们对经济高效地生产安全 EPS 聚合物的革命性研究。在本综述中,我们对 EPS 进行了分类,并讨论了其提取和表征方法。我们还总结了当前的药物输送应用,讨论了 EPSs 广泛工业商业化的局限性,同时强调了利用微生物 EPSs 的前景和对研究的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Polimery w medycynie
Polimery w medycynie Medicine-Medicine (all)
CiteScore
3.30
自引率
0.00%
发文量
9
审稿时长
53 weeks
期刊最新文献
Efficacy of sulforaphane in skin cancer animal models: A systematic review. Design of experiments and artificial neural networks as useful tools in the optimization of analytical procedure. High-filler content electrospun fibers from biodegradable polymers and hydroxyapatite: Toward improved scaffolds for tissue engineering. Interaction of meloxicam derivatives with phosphatidylcholine bilayers: A calorimetric study. Rheological properties of pharmaceutical substrates produced with Celugel.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1